New antiepileptic drugs. II. Clinical use.
Lee
B I
BI
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
D000085:Acetates / Q000009:adverse effects / Q000494:pharmacology; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects / Q000494:pharmacology*; D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids; D000078328:Felbamate; D005544:Forecasting; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D000077206:Gabapentin; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000494:pharmacology; D000077213:Lamotrigine; D000078330:Oxcarbazepine; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000009:adverse effects / Q000494:pharmacology; D000077236:Topiramate; D014227:Triazines / Q000009:adverse effects / Q000494:pharmacology; D020888:Vigabatrin; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D007555:Isoxazoles; D048448:Phenylcarbamates; D011409:Propylene Glycols; D014227:Triazines; D000077236:Topiramate; D005632:Fructose; D002220:Carbamazepine; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D020888:Vigabatrin; D000077213:Lamotrigine; D000078330:Oxcarbazepine; D000078328:Felbamate